|Articles|September 15, 2014
- BioPharm International-09-15-2014
- Volume 2014 eBook
- Issue 3
Biopharma Contract Manufacturing Prices Go Up—and Down
Author(s)William Downey
A dynamic market, industry consolidation, and demand fluctuations lead to a mixed picture of pricing results.
Advertisement
A dynamic market, industry consolidation, and demand fluctuations lead to a mixed picture of pricing results.
from BioPharm International’s 2014 Outsourcing Strategies eBook.
View other articles in the
.
Articles in this issue
over 11 years ago
Ensuring Sound Bioanalytical Methods Transferover 11 years ago
CMOs Gear Up for Biologics Manufacturing Challengesover 11 years ago
Weighing Clinical Trial Outsourcing Optionsover 11 years ago
Outsourcing Trends in Biopharmaceutical ManufacturingNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Priority Review of Subcutaneous Lecanemab Signals Shift in Alzheimer’s Treatment Delivery
2
FDA Fast Tracks Innovent’s Trispecific Antibody for Multiple Myeloma
3
HanchorBio–WuXi Biologics Partnership Targets Fusion Protein Development Challenges
4
GSK’s Arexvy Gains EU Approval for Adults Aged 18 Years and Older
5